Publication Name	World Journal of Diabetes
Manuscript ID	89962
Country	United States

Received	2023-11-18 17:59
Peer-Review Started	2023-11-18 18:00
To Make the First Decision
Return for Revision	2023-12-08 02:42
Revised	2023-12-16 23:03
Second Decision	2024-01-03 03:29
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-01-25 05:37
Articles in Press	2024-01-25 05:37
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-01-31 23:11
Typeset the Manuscript	2024-03-07 07:56
Publish the Manuscript Online	2024-03-15 09:49

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Roles of fibroblast growth factors in the treatment of diabetes
Manuscript Source	Invited Manuscript
All Author List	Chun-Ye Zhang and Ming Yang
ORCID	Author(s) ORCID Number Chun-Ye Zhang http://orcid.org/0000-0003-2567-029X Ming Yang http://orcid.org/0000-0002-4895-5864
Funding Agency and Grant Number
Corresponding Author	Ming Yang, DVM, PhD, Research Assistant Professor, Department of Surgery, University of Missouri, Room 2203, NextGen Precision Building, 1030 Hitt Street, Columbia, MO 65212, United States. yangmin@health.missouri.edu
Key Words	Fibroblast growth factors; Type 1 diabetes; Type 2 diabetes; Metabolic disorders; Treatment; Clinical trials
Core Tip	Diabetes affects about 422 million people worldwide, causing 1.5 million deaths each year. However, the incidence of diabetes is increasing, including both type 1 and type 2 diabetes. New therapies for diabetes are needed to prevent this increasing incidence. The fibroblast growth factor (FGF) family members play important roles in many metabolic disorders, including diabetes. To date, a total of 23 family members (FGF1-23) have been found in humans. Some FGFs, such as FGF-15, FGF-19, and FGF-21, have anti-diabetic functions in pre-clinical studies, and they are under investigation in clinical trials for examining the therapeutic effects in patients.
Publish Date	2024-03-15 09:49
Citation	Zhang CY, Yang M. Roles of fibroblast growth factors in the treatment of diabetes. World J Diabetes 2024; 15(3): 392-402
URL	https://www.wjgnet.com/1948-9358/full/v15/i3/392.htm
DOI	https://dx.doi.org/10.4239/wjd.v15.i3.392

Full Article (PDF)	WJD-15-392-with-cover.pdf
Full Article (Word)	WJD-15-392.docx
Manuscript File	89962-Review-FilipodiaCL.docx
Answering Reviewers	89962-Answering reviewers.pdf
Audio Core Tip	89962-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	89962-Conflict-of-interest statement.pdf
Copyright License Agreement	89962-Copyright license agreement.pdf
Peer-review Report	89962-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	89962-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	89962-Bing-Lin C-2.png
Scientific Editor Work List	89962-Scientific editor work list.pdf
CrossCheck Report	89962-CrossCheck.png
CrossCheck Report	89962-CrossCheck report.pdf